SEI Trust Company’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

SEI Trust Company’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-17,921	Closed	-$661K	–	1707
2014 Q1	$661K	Sell	17,921 -29,043	-62%	-$1.07M	0.01%	1036
2013 Q4	$1.8M	Buy	46,964 +23,005	+96%	+$726K	0.02%	723
2013 Q3	$656K	Buy	23,959 +21,413	+841%	+$507K	0.01%	1013
2013 Q2	$53K	Buy	+2,546	New	+$49.7K	﹤0.01%	1453

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SEI Trust Company's WX Position: Q2 2014 in Review

SEI Trust Company sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2014, closing a stake of 17,921 shares — an estimated $661K sold.

SEI Trust Company first reported a position in WX in Q2 2013 and held it in 4 quarters. The position peaked at $1.8M in Q4 2013. 154 funds tracked by Wall St. Rank hold WX as of Q2 2014.

SEI Trust Company reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2014 after selling out during the quarter.
SEI Trust Company sold 17,921 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2014, an estimated $661K.
SEI Trust Company first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 4 quarters.
SEI Trust Company's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.8M in Q4 2013.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2014.

Based on SEI Trust Company's 13F filing for Q2 2014, filed 22 Jul 2014.